Therapeutic Asset Ratings
414 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nano-Crystalline Megestrol Acetate Suspension
Colorectal Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
D
(26)
Nardraparin Calcium
Colorectal Cancer
RenJi Hospital
D
(26)
RAMIFENTANYL
Colorectal Cancer
Fudan University
N/A
D
(26)
RIFALDAZINE
Colorectal Cancer
Shaukat Khanum Memorial Cancer Hospital & Research Centre
N/A
D
(26)
Rocuronium
Colorectal Cancer
Fudan University
N/A
D
(26)
S-Ketamine
Colorectal Cancer
Fudan University
N/A
D
(26)
SUFENTANYL
Colorectal Cancer
Fudan University
N/A
D
(26)
syh2051
Colorectal Cancer
Fujian Cancer Hospital
N/A
D
(26)
sys6010
Colorectal Cancer
Fujian Cancer Hospital
N/A
D
(26)
Sasanlimab
Colorectal Cancer
Pfizer
P1
D
(24)
Bgb-3245
Colorectal Cancer
MapKure, LLC
P1
D
(21)
Enlituo®
Colorectal Cancer
Taizhou Mabtech Pharmaceutical Co.,Ltd
P3
NR
(0)
Ymn-136 Vaccine
Colorectal Cancer
West China Hospital
P1
NR
(0)
gpa33-cc;177lu-smartd2
Colorectal Cancer
SmartNuclide Biopharma
Early P1
NR
(0)
Showing 401 to 414 of 414 assets
Previous
Page 17 of 17
Next